These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6795096)

  • 1. Impact of cisplatin multiagent chemotherapy and total parenteral hyperalimentation on bowel obstruction caused by ovarian cancer.
    Tunca JC
    Gynecol Oncol; 1981 Oct; 12(2 Pt 1):219-21. PubMed ID: 6795096
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction.
    Abu-Rustum NR; Barakat RR; Venkatraman E; Spriggs D
    Gynecol Oncol; 1997 Mar; 64(3):493-5. PubMed ID: 9062158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of intestinal obstruction in ovarian cancer.
    Krebs HB; Helmkamp F
    Oncology (Williston Park); 1989 May; 3(5):25-31; discussion 31-2, 35-6. PubMed ID: 2577883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doctor, does this mean I'm going to starve to death?
    Whitworth MK; Whitfield A; Holm S; Shaffer J; Makin W; Jayson GC
    J Clin Oncol; 2004 Jan; 22(1):199-201. PubMed ID: 14701785
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensified nutrition as an adjunct to cytotoxic chemotherapy in gynaecological cancer patients.
    Nuutinen LS; Kauppila A; Ryhänen P; Niinimäki A; Kivinen S; Saarela M; Pakarinen A; Hollmén A
    Clin Oncol; 1982 Jun; 8(2):107-12. PubMed ID: 6809386
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients.
    Brard L; Weitzen S; Strubel-Lagan SL; Swamy N; Gordinier ME; Moore RG; Granai CO
    Gynecol Oncol; 2006 Oct; 103(1):176-80. PubMed ID: 16564074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A technique for managing terminally ill ovarian carcinoma patients.
    Chapman C; Bosscher J; Remmenga S; Park R; Barnhill D
    Gynecol Oncol; 1991 Apr; 41(1):88-91. PubMed ID: 1902811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diary of a woman physician suffering from cancer. 12. Struggle with intestinal obstruction].
    Osakabe Y
    Kangogaku Zasshi; 1986 Dec; 50(12):1404-7. PubMed ID: 3099040
    [No Abstract]   [Full Text] [Related]  

  • 9. [Continuous care of an expectant patient with ileus by central venous hyperalimentation].
    Washio H; Nishikawa M; Nakamura K; Tanaka H; Yamakawa S
    Josanpu Zasshi; 1984 Mar; 38(3):237-42. PubMed ID: 6429396
    [No Abstract]   [Full Text] [Related]  

  • 10. Salvage surgery due to bowel obstruction in advanced or relapsed ovarian cancer resulting in short bowel syndrome and long-life total parenteral nutrition: surgical and clinical outcome.
    Fotopoulou C; Braicu EI; Kwee SL; Kuhberg M; Richter R; Pietzner K; Feldheiser A; Bahra M; Schmidt SC; Sehouli J
    Int J Gynecol Cancer; 2013 Oct; 23(8):1495-500. PubMed ID: 24189059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of bowel obstruction due to newly diagnosed inoperable advanced ovarian cancer with medical therapy.
    Drakes TP
    West J Med; 1991 Jul; 155(1):76-7. PubMed ID: 1877243
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indications for total parenteral nutrition in surgery (author's transl)].
    Peeters R; Hendrickx L; Hubens A
    Acta Chir Belg; 1981; 80(2-3):75-81. PubMed ID: 6794274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of multiagent chemotherapy regimens in ovarian carcinoma: dose intensity analysis.
    Levin L; Simon R; Hryniuk W
    J Natl Cancer Inst; 1993 Nov; 85(21):1732-42. PubMed ID: 8411257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of hypervitaminosis A in a patient on long-term parenteral hyperalimentation.
    Seibert JJ; Byrne WJ; Golladay ES
    Pediatr Radiol; 1981 Feb; 10(3):173-4. PubMed ID: 6784095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study).
    Sutton GP; Bundy BN; Omura GA; Yordan EL; Beecham JB; Bonfiglio T
    Gynecol Oncol; 1991 Jun; 41(3):230-3. PubMed ID: 1869100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient management of small bowel obstruction in terminal ovarian cancer.
    Hopkins MP; Roberts JA; Morley GW
    J Reprod Med; 1987 Nov; 32(11):827-9. PubMed ID: 3123672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced adenocarcinoma of the lung with ftorafur, doxorubicin, cyclophosphamide, and cisplatin (FACP) and intensive iv hyperalimentation.
    Jordan WM; Valdivieso M; Frankmann C; Gillespie M; Issell BF; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(3-4):197-205. PubMed ID: 6786737
    [No Abstract]   [Full Text] [Related]  

  • 18. Home parenteral nutrition: Parenteral Nutrition Group.
    Med J Aust; 1980 Feb; 1(4):172-3. PubMed ID: 6154881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Palliative symptom control in malignant bowel obstruction due to advanced ovarian cancer].
    Alker K; Harnoncourt F
    Wien Med Wochenschr; 2006 May; 156(9-10):228-32. PubMed ID: 16830236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of patients with advanced ovarian carcinoma treated with debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide. Gynecologic Oncology Group of the Comprehensive Cancer Center.
    Wils JA
    Oncology; 1990; 47(2):115-20. PubMed ID: 2107480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.